Coproporphyrins I and III as Functional Markers of OATP1B Activity: In Vitro and In Vivo Evaluation in Preclinical Species

The Journal of Pharmacology and Experimental Therapeutics
Hong ShenYurong Lai

Abstract

Inhibition of organic anion-transporting polypeptide (OATP)1B function can lead to serious clinical drug-drug interactions, thus a thorough evaluation of the potential for this type of interaction must be completed during drug development. Therefore, sensitive and specific biomarkers for OATP function that could be used in conjunction with clinical studies are currently in demand. In the present study, preclinical evaluations were conducted to characterize the suitability of coproporphyrins (CPs) I and III as markers of hepatic OATP functional activity. Active uptake of CPs I and III was observed in human embryonic kidney (HEK) 293 cells singly expressing human OATP1B1 (hOATP1B1), hOATP1B3, cynomolgus monkey OATP1B1 (cOATP1B1), or cOATP1B3, as well as human and monkey hepatocytes. Cyclosporin A (100 mg/kg, oral) markedly increased the area under the curve (AUC) plasma concentrations of CPs I and III by 2.6- and 5.2-fold, while rifampicin (15 mg/kg, oral) increased the AUCs by 2.7- and 3.6-fold, respectively. As the systemic exposure increased, the excretion of both isomers in urine rose from 1.6- to 4.3-fold in monkeys. In agreement with this finding, the AUC of rosuvastatin (RSV) in cynomolgus monkeys increased when OATP1B inh...Continue Reading

Associated Clinical Trials

References

Jan 1, 1990·Nephron·M GebrilR Morton
Nov 1, 1972·The Journal of Clinical Investigation·N KaplowitzA Kappas
Dec 1, 1969·Clinica Chimica Acta; International Journal of Clinical Chemistry·M A Aziz, C J Watson
Oct 1, 1980·British Journal of Diseases of the Chest·J W Millar
Jul 1, 1993·Pharmaceutical Research·B Davies, T Morris
Mar 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John D ChesterMatthew T Seymour
Oct 22, 2003·Archives of Dermatology·Chad HivnorMaureen Poh-Fitzpatrick
Aug 4, 2004·Clinical Pharmacology and Therapeutics·Steven G SimonsonDennis W Schneck
Dec 21, 2006·Clinical Pharmacology and Therapeutics·Pertti J NeuvonenJanne T Backman
May 3, 2007·Clinical Pharmacology and Therapeutics·M K PasanenM Niemi
Feb 23, 2008·Toxicology·Josef OzerShelli Schomaker
Jul 22, 2008·Journal of Human Genetics·Suttasinee SuwannakulShun Higuchi
Jun 30, 2009·Chemico-biological Interactions·Scott D CampbellJinghai J Xu
Sep 30, 2009·British Journal of Pharmacology·A Kalliokoski, M Niemi
Jun 4, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Rune AmundsenAnders Asberg
Jan 12, 2011·British Journal of Clinical Pharmacology·Ulf DiczfalusyLeif Bertilsson
Jan 11, 2012·The Journal of Clinical Investigation·Evita van de SteegAlfred H Schinkel
Feb 27, 2013·Journal of Pharmaceutical Sciences·Yoshihisa ShitaraToshiharu Horie
Mar 20, 2013·Molecular Aspects of Medicine·Bruno Hagenbuch, Bruno Stieger
Apr 11, 2013·Molecular Pharmacology·Tom De BruynPieter P Annaert
Mar 13, 2014·British Journal of Clinical Pharmacology·Thomayant PrueksaritanontS Aubrey Stoch
May 20, 2014·British Journal of Clinical Pharmacology·Sreeneeranj KasichayanulaFrank LaCreta
Dec 11, 2014·Journal of Clinical Pharmacology·J Michael DavenportJürgen Venitz
Jan 13, 2015·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Tomoko WatanabeRikiya Ohashi
Sep 6, 2015·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Bridget L MorseYurong Lai
Sep 19, 2015·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Dallas Bednarczyk, Carri Boiselle

❮ Previous
Next ❯

Citations

Aug 27, 2016·Expert Opinion on Drug Metabolism & Toxicology·Andrew RowlandMichael J Sorich
Sep 18, 2016·Advanced Drug Delivery Reviews·Yan LiJames W Paxton
Jul 23, 2016·Clinical Pharmacology and Therapeutics·S W YeeK M Giacomini
Oct 27, 2016·Expert Opinion on Drug Metabolism & Toxicology·Daniella KovacsicsCsilla Özvegy-Laczka
Mar 21, 2018·European Journal of Drug Metabolism and Pharmacokinetics·Tony K L Kiang
Sep 4, 2018·CPT: Pharmacometrics & Systems Pharmacology·Takashi YoshikadoYuichi Sugiyama
Oct 14, 2018·The Journal of Pharmacology and Experimental Therapeutics·Shelby BarnettAleksandra Galetin
Apr 13, 2018·The Journal of Pharmacology and Experimental Therapeutics·Ayşe UfukAleksandra Galetin
Apr 12, 2017·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Rhishikesh ThakareA David Rodrigues
Jan 21, 2018·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Norikazu MatsunagaIkumi Tamai
Mar 1, 2018·Pharmacological Reviews·Fabian MüllerMartin F Fromm
Mar 23, 2017·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ravindranath Reddy GilibiliYurong Lai
Jul 30, 2020·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yueping ZhangHong Shen
Aug 30, 2017·Expert Opinion on Drug Metabolism & Toxicology·Eve-Irene Lepist, Adrian S Ray
Aug 12, 2018·Pharmaceutics·Ravindranath Reddy GilibiliSagnik Chatterjee
Jun 11, 2019·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Yingmin NieChunshan Gui
Jun 20, 2020·Drug Metabolism Reviews·Lianne J StevensEvita van de Steeg
Nov 1, 2020·The Journal of Pharmacology and Experimental Therapeutics·Sagnik ChatterjeeHong Shen
Dec 9, 2020·CPT: Pharmacometrics & Systems Pharmacology·Hiroyuki TakitaAleksandra Galetin
Apr 2, 2021·Biochemical Pharmacology·Jonny KinziHenriette E Meyer Zu Schwabedissen
Jan 19, 2021·Journal of Clinical Pharmacology·Sheng FengYuyan Jin
Sep 29, 2020·Journal of Medicinal Chemistry·David A TessManthena V S Varma

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.